Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons

Apoptosis

Volumn 10, Issue 6, 2005, Pages 1243-1259

  Chauvier, D ^a   Lecoeur, H ^a   Langonne A ^a   Borgne Sanchez, A ^a   Mariani, J ^b   Martinou, J C ^c   Rebouillat, D ^a   Jacotot, E ^a  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bax; Caspase 2; Checkpoint; Mitochondria; Neuronal apoptosis; Serum deprivation

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; ENZYME INHIBITOR; PHOSPHATIDYLSERINE; PROTEIN BAX; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SPECIFICITY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 2; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; NEURONS; PEPTIDES; PROTEIN TRANSPORT; RNA INTERFERENCE; SERUM;

ANIMALIA;

EID: 30944446002     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-1681-x     Document Type: Article

References (62)

1. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568.
2. Yuan J, Yankner B. Apoptosis in the nervous system. Nature 2000; 407: 802-809.
3. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1: 120-129.
4. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315-360.
5. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40: 401-413.
6. Rideout HJ, Stefanis L. Caspase inhibition: A potential therapeutic strategy in neurological diseases. Histol Histopathol 2001; 16: 895-908.
7. Nicotera P. Apoptosis and age-related disorders: Role of caspase-dependent and caspase-independent pathways. Toxicol Letters 2002; 127: 189-195.
8. Orrenius S, Zhivotovsky B, Nicotera P. Calcium: Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-565.
9. McLaughlin B, Hartnett KA, Erhardt JA, et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 2003; 100: 715-720.
10. Hartmann A, Hunot S, Michel PP, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 2875-2880.
11. Mogi M, Togari A, Kondo T, et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm 2000; 107: 335-341.
12. Gastard MC, Troncoso JC, Koliatsos VE. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 2003; 54, 393-398.
13. Chan SL, Mattson ML. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58: 167-190.
14. Deshmukh M, Vasilakos J, Deckwerth TL, et al. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol 1996; 135: 1341-1354.
15. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002; 297: 1352-1354.
16. Robertson JD, Enoksson M, Suomela M, et al. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803-29809.
17. Robertson JD, Gogvadze V, Kropotov A, et al. Processed caspase-2 can induce mitochondria-mediated apoptosis independently of its enzymatic activity. EMBO Rep 2004; 5: 643-648.
18. Troy CM, Shelanski ML. Caspase-2 redux. Cell Death Differ 2003; 10: 101-107.
19. Troy CM, Stefanis L, Greene LA, et al. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation in sympathetic neurons and PC12 cells. J Neurosci 1997; 17: 1911-1918.
20. Troy CM, Rabacchi SA, Friedman WJ, et al. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000; 20: 1386-1392.
21. Haviv R, Lindenboim L, Yuan J, Stein R. Need for caspase-2 in apoptosis of growth-factor-deprived PC12 cells. J Neurosci Res 1998; 52: 491-497.
22. Stefanis L, Troy CM, Qi H, et al. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J Neurochem 1997; 69: 1425-1437.
23. Stefanis L, Troy CM, Qi H, et al. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity. J Neurosci 1998; 18: 9204-9215.
24. Troy CM, Rabacchi SA, Xu Z, et al. Beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 2001; 77: 157-164.
25. Bergeron L, Perez GI, Macdonald G, et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304-1314.
26. Hermel E, Gafni J, Propp SS, et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ 2004; 11: 424-438.
27. Li H, Bergeron L, Cryns V, et al. Activation of caspase-2 in apoptosis. J Biol Chem 1997; 272: 21010-21017.
28. Lecoeur H, Chauvier D, Langonné A, et al. Fixed- and real-time cytofluorometric technologies for dynamic analysis of apoptosis in primary cortical neurons. Apoptosis 2004; 9: 157-169.
29. Susin SA, Lorenzo H, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.
30. Poser S, Impey S, Xia Z, et al. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 2003; 23: 4420-4427.
31. Caserta TM, Smith AN, Gultice AD, et al. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003; 8: 345-352.
32. Stefanis L, Park DS, Yan CY, et al. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis. J Biol Chem 1996; 271: 30663-30671.
33. Deshmukh M, Kuida K, Johnson EM Jr. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J Cell Biol 2000; 150: 131-143.
34. Deckwerth TL, Elliott JL, Knudson CM, et al. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 1996; 17: 401-411.
35. Deshmukh M, Johnson EM. Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 1998; 21: 695-705.
36. Putcha GV, Deshmukh M, Johnson EM. BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases. J Neurosci 1999; 19: 7476-7485.
37. Karpinich NO, Tafani M, Rothman RJ. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 2002; 277: 16547-1652.
38. Tafani M, Cohn JA, Karpinich NO, et al. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002; 277: 49569-49576.
39. Guo Y, Srinivasula SM, Druilhe A, et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430-13437.
40. Wood DE, Thomas A, Devi LA, et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998; 17: 1069-1078.
41. Choi WS, Lee EH, Chung CW, et al. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 2001; 77: 1531-1541.
42. Marsden VS, Ekert PG, Van Delft M, et al. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 2004, 165; 775-780.
43. Troy CM, Rabacchi SA, Hohl JB, et al. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 2001; 21: 5007-5016.
44. Henshall DC, Skradski SL, Bonislawski DP, et al. Caspase-2 activation is redundant during seizure-induced neuronal death. J Neurochem 2001; 77: 886-895.
45. Ekert PG., Read SH, Silke J, et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 2004; 165, 835-842.
46. Qin Y, Van den Hoek TL, Wojcik K, et al. Caspase-dependent cytochrome c release and cell death in chick cardiomyocytes following simulated ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2004; 286: H2280-2286.
47. Wang L, Miura M, Bergeron L, et al. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78, 739-750.
48. Adrain C, Creagh EM, Martin SJ. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 2001; 20: 6627-6636.
49. Paroni G, Henderson C, Schneider C. Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV-or tumor necrosis factor-dependent cell death requires caspase-3. J Biol Chem 2001; 276: 21907-21915.
50. Prokop A, Wrasidlo W, Lode H, et al. Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner. Oncogene 2003; 22: 9107-9120.
51. Paroni G, Henderson C, Schneider C, et al. Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J Biol Chem 2002; 277: 15147-15161.
52. Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem 1998; 273: 24535-24542.
53. Susin SA, Lorenzo H, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-394.
54. O'Reilly LA, Ekert P, Harvey N, et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002; 9: 832-841.
55. Mancini M, Machamer CE, Roy S, et al. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 2000; 149: 603-612.
56. Ohtsuka T, Ryu H, Minamishima YA, et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6: 121-128.
57. Baliga BC, Colussi PA, Read SH, et al. Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. J Biol Chem 2003; 278: 4899-4905.
58. Wood DE, Newcomb EW. Cleavage of Bax enhances its cell death function. Exp Cell Res 2000; 256: 375-382.
59. Cao X, Deng X, May WS. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 2003; 102: 2605-2614.
60. Sawada M, Hayes P, Matsuyama S. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 2003; 5: 352-357.
61. Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003; 423: 456-461.
62. Ohtsuka T, Ryu H, Minamishima YA, et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6, 121-128.